Literature DB >> 7924435

Cytotoxic T lymphocyte responses against measles virus.

F G UytdeHaag1, R S van Binnendijk, M J Kenter, A D Osterhaus.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7924435     DOI: 10.1007/978-3-642-78530-6_9

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  6 in total

1.  Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides.

Authors:  C D Partidos; P Vohra; M W Steward
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

2.  Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity.

Authors:  F Bouche; W Ammerlaan; F Berthet; S Houard; F Schneider; C P Muller
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

3.  Measles virus-specific antibody levels in individuals in Argentina who received a one-dose vaccine.

Authors:  Marcelo H Argüelles; Mariana L Orellana; Alejandro A Castello; Guillermo A Villegas; Matilde Masini; Alejandra L Belizan; Silvia González Ayala; Osmar D Vera; Graciela Glikmann
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

4.  Measles virus neurovirulence and host immunity.

Authors:  Michael Oglesbee; Stefan Niewiesk
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

5.  Major histocompatibility complex haplotype determines hsp70-dependent protection against measles virus neurovirulence.

Authors:  Thomas Carsillo; Mary Carsillo; Zachary Traylor; Päivi Rajala-Schultz; Phillip Popovich; Stefan Niewiesk; Michael Oglesbee
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

6.  Cytotoxic T-lymphocyte precursor frequencies in BALB/c mice after acute respiratory syncytial virus (RSV) infection or immunization with a formalin-inactivated RSV vaccine.

Authors:  R A Tripp; L J Anderson
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.